Clinical applications

IMMray™ technology has been developed with the aim to respond to unmet clinical needs. IMMray™ has already shown its applicability within two main disease areas – oncology (pancreatic cancer) and autoimmune diseases with the main focus on Systemic Lupus Erythematosus (SLE).



Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form.

Press releases
Financial reports